Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene

Cell

Volumn 73, Issue 7, 1993, Pages 1445-1454

  Shultz, Leonard D ^a   Schweitzer, Peter A ^a   Rajan, T V ^b   Yi, Taolin ^c   Ihle, James N ^c   Matthews, R James ^d   Thomas, Matthew L ^d   Beier, David R ^e  

^a JACKSON LABORATORY   (United States)

^b Department of Pathology University Connecticut Health Center Farmington ^*  (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE;

ANIMAL CELL; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME 6; CHROMOSOME MAP; DNA DETERMINATION; DNA SEQUENCE; GENE EXPRESSION; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

ANIMAL; BASE SEQUENCE; CHROMOSOME MAPPING; COMPARATIVE STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MACROPHAGES; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN-TYROSINE-PHOSPHATASE; RNA SPLICING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA; MURINAE;

EID: 0027197067     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(93)90369-2     Document Type: Article

References (68)

1. Retroviral infection of accessory cells and the immunological paradox in AIDS
2. Mapping genes in the mouse using single-strand conformation polymorphism analysis of recombinant inbred strains and interspecific crosses
3. A study of Russell bodies in human monoclonal plasma cells by means of immunofluorescence and electron microscopy
4. The Src family of tyrosine protein kinases in hemopoietic signal transduction
5. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene
6. Regional mapping of cKi-ras proto-oncogene on mouse chromosome 6 by in situ hybridization
7. Oncogenes and signal transduction
8. tdic(9; 12): a nonrandom chromosome abnormality in childhood B cell precursor acute lymphoblastic leukemia: a pediatric oncology group study
9. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
10. Mutations in mice that influence natural killer (NK) cell activity
11. Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes
12. A genetic map of the mouse suitable for typing intraspecific crosses
13. Oncogenes, growth factors, and signal transduction
14. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases
15. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew
16. H gene family repertoires of viable motheaten mice
17. Plasma cell alterations in ulcerative colitis
18. Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology
19. Studies on transformation of Escherichia coli with plasmids
20. Lymphohemopoiesis in culture is prevented by interaction with adherent bone marrow cells from mutant viable motheaten mice
21. The Ly-1 B cell lineage
22. The development and repertoire of B-1 cells (CD5 B cells)
23. Germline V genes encode viable motheaten mouse auto-antibodies against thymocytes and red blood cells
24. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins
25. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β
26. Phorbol ester responsiveness of murine Ly-1-lineage B cells from normal and viable motheaten mutant mice
27. v) mutant mice. III. Normal mouse bone marrow cells enable mev/mev prothymocytes to generate thymocytes after intravenous transfer
28. Suppressive effects of monocytic cells and transforming growth factor-β on natural killer cell differentiation in autoimmune viable motheaten mutant mice
29. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation
30. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences
31. Reticulosis [familial histocytic familial hematophagocytic reticulosis; erythrophagocytic lymphohistiocytosis, familial; FEL; reticuloendotheliosis, familial with eosinophilia; Omenn Syndrome]
32. v) mutant mice. II. Description of a micro-environmental defect for the generation of terminal deoxynucleotidyl-transferase-positive bone marrow cells in vitro
33. Familial reticuloendotheliosis: cocurrence of disease in five siblings
34. Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis
35. Protein tyrosine phosphorylation through the slgM receptor of B-1 lymphocytes
36. Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice
37. Regulation of lymphocyte function by protein phosphorylation
38. Isolation of a src homology 2-containing tyrosine phosphatase
39. Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6)
40. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency
41. Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia
42. New recurring chromosomal translocations in childhood acute lymphoblastic leukemia
43. The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity
44. Synthesis of abnormal immunoglobulins by hybridomas from autoimmune “viable motheaten” mutant mice
45. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases
46. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1
47. Pleiotropic effects of deleterious alleles at the “motheaten” locus
48. Hematopoiesis and models of immunodeficiency
49. Immunological mutants of the mouse
50. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins
51. Genetically determined murine models of immunodeficiency
52. Hematopoietic stem cell function in motheaten mice
53. “Viable motheaten”: a new allele at the motheaten locus. I. Pathology
54. Development of plasmacytoid cells with Russell bodies in autoimmune “viable motheaten” mice
55. The mouse mutant “motheaten.” I. Development of lymphocyte populations
56. + B cells in viable motheaten and normal mice
57. Protein kinases and phosphatases are involved in erythropoietin-mediated signal transduction
58. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
59. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev)
60. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation
61. Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1
62. Association of hematopoietic cell phosphatase (HCP) with c-Kit following stimulation with c-kit ligand
63. Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification
64. Assignment of a novel protein tyrosine phosphatase gene (hcph) to mouse chromosome 6
65. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12–p13
66. Purification and characterization of a protein tyrosine phosphatase containing SH2 domains